The use of vaginal mesh implants is to be the subject of a full, retrospective audit by the Australia government, following numerous complaints of complications and pain from women who have had the surgery. Over 100,000 women have received the implants, which are used to treat incontinence and prolapse, over the past decade, according to the NHS. Campaigners argue that patients have been subject to unacceptable risks. Official figures estimate the rate of complications at 3-5%, but recent studies suggest it could be as high as 10-15%. UK and New Zealand have already restricted the use of the products.
The use of vaginal mesh implants is to be the subject of a full, retrospective audit by the UK government, following numerous complaints of complications and pain from women who have had the surgery. Over 100,000 women have received the implants, which are used to treat incontinence and prolapse, over the past decade, according to the NHS. Campaigners argue that patients have been subject to unacceptable risks. Official figures estimate the rate of complications at 3-5%, but recent studies suggest it could be as high as 10-15%. Australia and New Zealand have already restricted the use of the products.